Molbio Diagnostics' board approved the financial results for the quarter ended June 30, 2026. Key management personnel are now authorized to determine the materiality of events for timely disclosures.
Molbio Diagnostics Limited has scheduled an Earnings Conference Call on Tuesday, September 08, 2026, at 04:00 PM IST to discuss the financial performance for the quarter ended June 30, 2026.
Molbio Diagnostics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
